» Articles » PMID: 38956095

Identifying Bayesian Optimal Experiments for Uncertain Biochemical Pathway Models

Overview
Journal Sci Rep
Specialty Science
Date 2024 Jul 2
PMID 38956095
Authors
Affiliations
Soon will be listed here.
Abstract

Pharmacodynamic (PD) models are mathematical models of cellular reaction networks that include drug mechanisms of action. These models are useful for studying predictive therapeutic outcomes of novel drug therapies in silico. However, PD models are known to possess significant uncertainty with respect to constituent parameter data, leading to uncertainty in the model predictions. Furthermore, experimental data to calibrate these models is often limited or unavailable for novel pathways. In this study, we present a Bayesian optimal experimental design approach for improving PD model prediction accuracy. We then apply our method using simulated experimental data to account for uncertainty in hypothetical laboratory measurements. This leads to a probabilistic prediction of drug performance and a quantitative measure of which prospective laboratory experiment will optimally reduce prediction uncertainty in the PD model. The methods proposed here provide a way forward for uncertainty quantification and guided experimental design for models of novel biological pathways.

References
1.
Bustin S . Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol. 2000; 25(2):169-93. DOI: 10.1677/jme.0.0250169. View

2.
Breitling R, Gilbert D, Heiner M, Orton R . A structured approach for the engineering of biochemical network models, illustrated for signalling pathways. Brief Bioinform. 2008; 9(5):404-21. DOI: 10.1093/bib/bbn026. View

3.
Pappalardo F, Russo G, Musuamba Tshinanu F, Viceconti M . In silico clinical trials: concepts and early adoptions. Brief Bioinform. 2018; 20(5):1699-1708. DOI: 10.1093/bib/bby043. View

4.
Nijhout H, Best J, Reed M . Systems biology of robustness and homeostatic mechanisms. Wiley Interdiscip Rev Syst Biol Med. 2018; 11(3):e1440. DOI: 10.1002/wsbm.1440. View

5.
Viceconti M, Pappalardo F, Rodriguez B, Horner M, Bischoff J, Musuamba Tshinanu F . In silico trials: Verification, validation and uncertainty quantification of predictive models used in the regulatory evaluation of biomedical products. Methods. 2020; 185:120-127. PMC: 7883933. DOI: 10.1016/j.ymeth.2020.01.011. View